BIOG-B Performance & Benchmarks - -21.3% in 12m
The Total Return for 3m is -2.1%, for 6m -17.3% and YTD -9.9%. Compare with Peer-Group: Biotechnology
Performance Rating
3.46%
#33 in Peer-Group
Rel. Strength
22.92%
#5911 in Stock-Universe
Total Return 12m
-21.30%
#93 in Peer-Group
Total Return 5y
-6.69%
#40 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 35.3 |
| P/E Forward | - |
| High / Low | SEK |
|---|---|
| 52 Week High | 130.65 SEK |
| 52 Week Low | 93.45 SEK |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 28.94 |
| Buy/Sell Signal +-5 | -1.74 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: BIOG-B (-21.3%) vs XBI (-13.5%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Short Term Performance
| Symbol | 1w | 1m | 3m |
|---|---|---|---|
| BIOG-B | -1.4% | -7.25% | -2.1% |
| ABVX | 9.78% | 864% | 888% |
| ABVX | 2.88% | 838% | 908% |
| PROK | -15.0% | 368% | 213% |
Long Term Performance
| Symbol | 6m | 12m | 5y |
|---|---|---|---|
| BIOG-B | -17.3% | -21.3% | -6.69% |
| RGC | 0.0% | 5,109% | 4,677% |
| DRUG | -0.68% | 2,811% | 25.1% |
| ABVX | 1,102% | 508% | 519% |
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.28% | 52.4% | 91.2% | 23.8 | 14.3 | 0.24 | 13.8% | 4.55% |
| UTHR NASDAQ United Therapeutics |
-4.4% | -12.3% | 136% | 11.2 | 10.9 | 1.43 | 72.0% | 9.29% |
| AMGN NASDAQ Amgen |
5.69% | -8.38% | 39.4% | 28.1 | 14.8 | 1.03 | -30.1% | 9.31% |
| NBIX NASDAQ Neurocrine Biosciences |
2.02% | -9.42% | 4.24% | 44.8 | 25.6 | 0.27 | -40.1% | 34.7% |
| BIM PA Biomerieux |
7.16% | 29.7% | -6.01% | 32.6 | 25.9 | 1.56 | -45.1% | -33.6% |
| PTCT NASDAQ PTC Therapeutics |
6.7% | 53.9% | 9.31% | 7.57 | 5.51 | 0.81 | - | 88.6% |
| KMDA NASDAQ Kamada |
-4.65% | 34.5% | -15.7% | 26.5 | 23.9 | 0.89 | 60.0% | 40.6% |
| LONN SW Lonza |
1.24% | -2.07% | 1.21% | 54.5 | 34.5 | 1.29 | 5.20% | -7.55% |
Performance Comparison: BIOG-B vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BIOG-B
| Total Return (including Dividends) | BIOG-B | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -7.25% | 3.29% | 2.30% |
| 3 Months | -2.10% | 3.28% | 14.32% |
| 12 Months | -21.30% | -13.50% | 16.19% |
| 5 Years | -6.69% | -24.51% | 106.47% |
| Trend Stabilty (consistency of price movement) | BIOG-B | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -72.3% | 14.7% | 88.4% |
| 3 Months | 0.8% | 85.3% | 97.4% |
| 12 Months | -47.4% | -84.8% | 49.8% |
| 5 Years | 57.3% | -50.4% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | 17 %th | -10.21% | -9.34% |
| 3 Month | 44 %th | -5.21% | -14.36% |
| 12 Month | 54 %th | -9.01% | -32.26% |
| 5 Years | 81 %th | 23.59% | -54.81% |
FAQs
Does BioGaia (publ) (BIOG-B) outperform the market?
No,
over the last 12 months BIOG-B made -21.30%, while its related Sector, the SPDR S&P Biotech (XBI) made -13.50%.
Over the last 3 months BIOG-B made -2.10%, while XBI made 3.28%.
Performance Comparison BIOG-B vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
BIOG-B vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1% | -9.6% | -23% | -37% |
| US NASDAQ 100 | QQQ | -1.4% | -9.7% | -25.8% | -42% |
| German DAX 40 | DAX | -0.5% | -7.8% | -27.6% | -51% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.4% | -10.3% | -26.5% | -41% |
| Hongkong Hang Seng | HSI | -0.5% | -11.5% | -45.5% | -63% |
| India NIFTY 50 | INDA | 1.2% | -1.8% | -20.6% | -14% |
| Brasil Bovespa | EWZ | 0.7% | 0.7% | -24.1% | -23% |
BIOG-B vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.3% | -6.2% | -22.8% | -48% |
| Consumer Discretionary | XLY | -0.8% | -9.1% | -13.2% | -40% |
| Consumer Staples | XLP | 0.5% | -5.8% | -19.6% | -26% |
| Energy | XLE | -1.2% | -10.1% | -18.4% | -18% |
| Financial | XLF | -0.1% | -7.3% | -19.8% | -43% |
| Health Care | XLV | 2.5% | -4% | -6.9% | -10% |
| Industrial | XLI | -0.5% | -10.3% | -27.9% | -42% |
| Materials | XLB | 2.5% | -7.2% | -17.1% | -18% |
| Real Estate | XLRE | 1.8% | -7.2% | -18.9% | -25% |
| Technology | XLK | -1.9% | -11% | -31.6% | -42% |
| Utilities | XLU | -3% | -12.2% | -28.9% | -42% |
| Aerospace & Defense | XAR | -0% | -9.9% | -41% | -66% |
| Biotech | XBI | 0.7% | -10.5% | -9.8% | -8% |
| Homebuilder | XHB | 2.1% | -10.6% | -11.8% | -8% |
| Retail | XRT | 2.4% | -9.1% | -15.6% | -23% |
BIOG-B vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -6% | -16.1% | -19.4% | -24% |
| Natural Gas | UNG | 0.6% | 3.8% | -1.3% | -22% |
| Gold | GLD | 1% | -6.6% | -34.5% | -55% |
| Silver | SLV | 4.7% | -8.8% | -34.2% | -48% |
| Copper | CPER | 22.7% | 6% | -19.6% | -26% |
BIOG-B vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -2.6% | -6.1% | -18.5% | -17% |
| iShares High Yield Corp. Bond | HYG | -1.3% | -7.4% | -21.1% | -30% |